Literature DB >> 7229701

Experimental neurogenic pulmonary edema. Part 1: The role of systemic hypertension.

J T Hoff, M Nishimura, J Garcia-Uria, S Miranda.   

Abstract

Neurogenic pulmonary edema (NPE) was produced consistently in normal cats by increasing intracranial pressure with an intraventricular infusion of mock cerebrospinal fluid. The usual elevation of systemic arterial pressure (SAP) that follows severe intracranial hypertension (the "Cushing response") was controlled by blood withdrawal at variable rates to achieve and maintain constant cerebral perfusion pressure (CPP) in three groups of cats of 50, 20, and 0 mm Hg, respectively, for 30 minutes. In this model, NPE occurs in the absence of increased SAP and in the presence of decreasing CPP. These results indicate that systemic arterial hypertension is not an essential stimulus for the development of NPE, and suggest that the lungs are directly affected by the intense sympathetic discharge evoked by severe intracranial hypertension.

Entities:  

Mesh:

Year:  1981        PMID: 7229701     DOI: 10.3171/jns.1981.54.5.0627

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  4 in total

Review 1.  Non-cardiogenic pulmonary edema complicating electroconvulsive therapy: short review of the pathophysiology and diagnostic approach.

Authors:  Janaki R Manne; Yusuf Kasirye; Narendranath Epperla; Romel J Garcia-Montilla
Journal:  Clin Med Res       Date:  2011-10-26

2.  Early embolization for ruptured aneurysm in acute stage of subarachnoid hemorrhage with neurogenic pulmonary edema.

Authors:  T Meguro; K Terada; N Hirotsune; S Nishino; T Asano; T Manabe
Journal:  Interv Neuroradiol       Date:  2007-06-27       Impact factor: 1.610

3.  Isolated Pulmonary Edema without Myocardial Stunning in Brainstem Strokes.

Authors:  John C Probasco; Tiffany Chang; David Victor; Paul Nyquist
Journal:  J Neurol Transl Neurosci       Date:  2014

4.  A change of position for neurogenic pulmonary edema.

Authors:  Scott A Marshall; Paul Nyquist
Journal:  Neurocrit Care       Date:  2008-11-15       Impact factor: 3.210

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.